Summary.-Eleven human bladder carcinomata of different degrees of differentiation were implanted in mice immunosuppressed by thymectomy, anti-thymocyte serum and x-rays. Seven carcinomata grew well and one poorly and 3 produced mainly fibrous nodules in the mice. Normal human bladder tissues were grown from 4 other patients. The administration of a haematoporphyrin derivative (HpD), followed 24 h later by exposure to white light, caused marked destruction of tumours but little or none of normal bladder tissues. HpD or light alone caused no damage to tumours or normal tissues.
It is suggested that photodynamic therapy may be applicable in the treatment of superficial transitional cell carcinoma of the bladder.
PORPHYRINS are powerful photodynamic agents which can sensitize tissues to light (Blum, 1964; Diamond et al., 1972) . Animal tumours take up and retain porphyrins selectively (Auler and Banzer, 1942; Figge, Weiland and Manganiello, 1948) , and clinical studies have shown that this also occurs in patients with a variety of epithelial tumours (Gray et al., 1967; Lipson, Baldes and Olsen, 1964; Gregoire et al., 1968; Leonard and Beck, 1971; Kyriazis, Balin and Lipson, 1973) . It has often been suggested that the photosensitizing action of porphyrins might be used therapeutically, but it was not until recently that the destruction of an animal tumour (a rat glioma) with haematoporphyrin and light was reported (Diamond et al., 1972) .
Most tumours do not lend themselves to phototherapy because they are deeply situated. However, with modern light sources and light transmission systems, phototherapy might be used for accessible tumours such as carcinoma of the bladder. There have been no previous reports regarding the localization of porphyrins in carcinoma of the bladder, or on the differential destruction of normal and malignant tissues using light and porphyrins. This study was therefore made to discover whether a derivative of haematoporphyrin (hereafter called HpD) (Lipson et al., 1961 ) is selectively taken up by human transitional cell carcinoma of the bladder growing in immunosuppressed mice (Berenbaum et al., 1974) , and whether such carcinomata cani be destroyed by a combined treatment with light and HpD which does not affect normal bladder tissues. HpD was used because, of the porphyrins tested to date, it is the best localized and visualized by its fluorescence in malignant tumours (Lipson et al., 1961; Barker, Henderson and Storey, 1970) .
MATERIALS AND METHODS
Male and female CBA mice were thymectomized when 5-9 weeks old; 7 days later they received the first of 4 doses of 0-5 ml of rabbit anti-mouse thymocyte serum (ATS) given on alternate days; ATS was prepared according to the method of Levey Medawar (1966) . The mice were then given 300 rad whole body radiation in a Stabilipan x-ray machine (225 kV, 27 rad/min, 1 mm Cu filter). Implants of tumour and other tissues were made wNithin 2 weeks of irradiation and the mice were subsequently treated with 0 25 ml of ATS on Mondays, Wednesdays and Fridays until they were sacrificed. Bladder carcinomata from 11 patients and normal bladder mucosa and muscle from 4 patients were placed in Eagle's minimal essential medium with added gentamicin (20 mg/i) and kept at 4°C until implanted (generally within 3 h). The source and histological grade (Dukes, 1959) of the tissues are given in Table 1 . The tissues were finely minced writh scissors and 0-2 ml of mince or 5-10 mm3 of more solid material were injected subcutaneously into both flanks of each mouse of a group which varied in size depending on the amount of tissue available.
The mice were used for experiments 9-30 days after implantation, when the nodules appeared to be increasing in size. It was not possible at the time of treatment to distinguish nodules containing tumour from those containing fibrous tissue only (Berenbaum et al., 1974) , except in those mice with implants older than 30 days, when the increase in size was obvious.
The HpD was prepared according to a method previously described (Lipson et al., 1961) . Commercial haematoporphyrin hydrochloride (Koch-Light) was dissolved in 500 (v/v) it wAas filtered and 3 0 sodium acetate in distilled water added to the solution until a precipitate formed at approximately pH 5.
This Mwas then filtered off, washed thoroughly with sterile pyrogen-free distilled wrater and dried at room temperature in the dark. This crystalline derivative (HpD) was then dissolved in 04 N sodium hydroxide and the pH adjusted to 7-4 with hydrochloric acid. Solutions containing 1 mg/ml were sterilized by Millipore filtration and stored in ampoules at 4°C. A single batch was prepared and used in all these experiments as it has been shown that different batches vary widely in their localizing ability (Gray et al., 1967) . A standard dose of 0-2 mg HpD per mouse was injected intraperitoneally 24 h before exposure of the nodules to light, the abdomen having been shaved before the injection.
The light source was a 400 watt CompactSource Iodide light (Thorn Lighting). The beam was directed upwards with a 450 mirror through a 4 cm diameter perspex rod 1 m long and then through a heat filter (a 2 cm layer of 500 copper sulphate). It delivered approximately 20,000 foot candles of light 10 cm from the distal end of the rod.
The mice were anaesthetized with Avertin (bromethol) and placed in a metal receptable with a 1 cm2 aperture in which the nodule wzas centred. All right-sided nodules were exposed to the light through the aperture for 30 min and the left-sided nodules used as unexposed controls. Measurement by implanted thermocouples in a group of 10 mice showed that exposure to light raised the The mice were killed 48 h after exposure to light and the nodules fixed in formalin. Sections stained with haematoxylin and eosin were coded and randomized, then examined by one of us without knowledge of the treatment given.
Nodules were classified as consisting of: (1) tumour, (2) normal epithelium, (3) normal muscle, (4) both normal epithelium and muscle, (5) fibrous tissue only, (6) unidentifiable recentlv necrotic tissue.
In order to follow the distribution of HpD, tumour-bearing mice were killed 24 h after receiving HpD and their organs, and frozen sections of their tumours, examined in u.v. light, using a Reichert Zetopan microscope fitted with an HB200 mercury vapour lamp, 3 mm BG12 and 2 mm BG38 primary filters and 1-5 mm OGI and 1 mm GG9 secondary filters. Fig. 1) Seven of the 11 carcinomata grew well (A-G); most of the implanted nodules contained solid areas of tumour similar in structure to the original tumour and with frequent mitoses (Fig. 2a) Implants of normal bladder tissue (M, N, 0, P) grew well, the epithelium generally containing moderate numbers of mitotic figures and tending to form a cyst (Fig. 3) .
RESULTS

Growth of implants (
Localization of HpD
Twenty-four h after injecting HpD the nodules were brightly fluorescent and there was a halo of red fluorescence in the surrounding skin and subcutaneous tissues. The nodules of 2 of the 81 HpD treated mice (* in Fig. 1) were not fluorescent and in one of these the intestine fluoresced faintly. It is therefore likely that in these 2 the HpD had inadvertently been injected into the gut, from which it is poorly absorbed, rather than into the peritoneum, and these mice are accordingly excluded from further consideration.
Nodules containing tumour could not be distinguished by their fluorescence from nodules containing normal bladder or fibrous tissue only. The lymph nodes were also fluorescent at that time, but no other tissues.
In frozen sections, the connective tissue capsule around the nodules was intensely fluorescent and the tumour fluoresced weakly but we could detect no fluorescence in normal bladder tissues. Thqre was no macroscopically visible fluorescence in organs of mice which had not been given HpD and sections of these showed no red fluorescence in anv tissue examined. (Fig. 2b) (Fig. 3b) .
At 48 h after irradiation, cells in damaged tissue showed pyknosis and karyorrhexis with eosinophilic cytoplasm, or complete nuclear dissolution. Sufficient histological pattern usually remained to identify the damaged tissue but in a few nodules necrosis was so marked that the tissue was unidentifiable. Damaged nodules sometimes showed interstitial haemorrhage.
The skin over nodules treated with HpD and light showed damage varying from karyorrhexis of epidermal and hair follicle cells to necrosis and ulceration. The subcutaneous connective tissue was oedematous, infiltrated with polymorphs and sometimes haemorrhagic, and the abdominal wall showed muscle fibre necrosis.
The histological findings are summarized in Fig. 1 (5) or none at all (13).
DISCUSSION
Our findings show unequivocally that human bladder carcinomata growing in immunosuppressed mice are severely damaged by combined treatment with HpD and light whereas normal bladder epithelium and muscle are comparatively resistant to this treatment. It is possible therefore that an effective treatment for bladder carcinoma might be based on this procedure. However, two problems arise. First, with the technique we used, light of sufficient intensity appeared to penetrate only shallowly. The largest nodules were 6 mm in diameter and although tumour was destroyed at all levels in most nodules, there were often deeply situated remnants that may have been viable. However, light was delivered through intact skin; this effectively screens the shorter wavelengths (Bachem and Reed, 1931) which are the principal activators of HpD fluorescence. In fact, we found it necessary to shave the mice since otherwise exposure to light for as much as an hour caused no tumour damage. The extent to which sufficient light would penetrate a tumour not shielded by skin is unknown but it may be no more than 5-10 mm, in which case this form of treatment could not be used for deeply infiltrating growths unless more powerful cool light sources become available. Second, it is possible that part of the damage to these nodules is due to damage to their vascular supply. We observed that HpD fluorescence was more intense in the connective tissue immediately around the tumour nodules than within the nodules themselves, and we have seen this with implants of other types of tumour. A fluorescent halo has also been observed with transplanted mouse tumours (Lipson et al., 1961) and we have noted a similar distribution with fluorescein. It is possible therefore that the tumour damage observed by us and others (Diamond et al., 1972; Dougherty, 1974) is due to damage to blood vessels as they pass through the damaged surrounding connective tissues. The apparently selective production of damage in bladder carcinoma compared with normal bladder tissue might accordingly be due not to inherent differences between carcinomatous and normal tissues as they exist in the patient, but to a greater vulnerability to ischaemia of implanted tumours compared with normal tissues. This factor is unlikely to be of overriding importance for, in the great majority of nodules that were not totally destroyed, the distribution of damage was clearly orientated towards the source of light anid any surviving tissues were in the deep, relatively shielded part of the nodule. As fluorescence microscopy of frozen sections showed a clear difference in uptake of HpD between tumour and normal bladder tissues, it is most likely that their different susceptibilities to photodynamic damage are due largely to this factor.
However, there were occasional nodules in which damage was irregularly distributed, and other factors may have operated in these. It may be possible to resolve this difficulty by experiments oIn spontaneous, or primary, carcinogeninduced tumours.
Studies in progress suggest that some implants of bladder carcinoma are destroyed by the treatment described, as they show no histological evidence of surviving tumour tissue 2 months later. Other nodules regrow, presumably those in which deep tumour tissue has survived. It is possible that these can be completely destroyed by repeated treatments spaced to allow removal of overlying necrotic tumour.
Photodynamic therapy appears promising for human bladder carcinoma, especially as we have found, by fluorescence cytoscopy and examination of surgically removed material, that HpD given to patients is selectively taken up by bladder carcinomata (to be published). However, because of the problem of light transmission through tissue, it would perhaps be most suitable for the treatment of widespread superficial carcinoma of the bladder, for which present methods of intracavitary therapy are only partly successful. It might also be used prophylactically in the treatment of recurrent cancer of the bladder, for HpD is taken up selectively by early and in situ carcinoma in other sites (Gray et al., 1967; Gregoire et al., 1968; Leonard and Beck, 1971) .
